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script, ifTo the Editor
Concerning the published article " Saha, Srishti, et al. Increasing
antibiotic resistance in Clostridioides difficile: A systematic review
and Meta-analysis. Anaerobe 58 (2019): 35e46.” [1]. We read this
manuscript with interest and found some drawbacks in the catego-
rization of data implementation.
The resistance rate of C. difficile to some antibiotics was investi-
gated in this article. Antibiotic resistance data were extracted from
reports in the searches of Ovid MEDLINE In Process & Other Non-
Indexed Citations, Ovid MEDLINE, Ovid Embase, Ovid Cochrane Cen-
tral Register of Controlled Trials, Ovid Cochrane Database of System-
atic Reviews, Web of Science, and Scopus from inception through
March 31, 2017 database searches. Eventually, 60 articles were
used for the final analysis. Subgroup analysis was performed by
study period, continent, antibiotic resistance testing method. Data
of ribotype 027 were analyzed separately. There was no mention
of quality assessment of the included studies in this meta-analysis.
All antibiotic susceptibility testing’s (AST) guidelines were grouped
as the same category and were analyzed; whereas for some of the
antibiotics breakpoints there were variations between AST guide-
lines (Some of these differences were shown in Table 1) [2,3].
In this study, the reports were used in theMeta-analysis without
performing an appropriate quality assessment which means aggre-
gating resistance rate of isolate that do not have a clear origin or has
been isolated from a particular section of the hospital. So, the bias
risk of the low-quality articles was confirmed. The result, due toAST breakpoint (mg/l) R >
5
cile and some article used S.cy in this method, was affected. According to the manu-
the articles reported the number of susceptible, intermedi-
ate resistance and resistant strains, only the number of resistant
isolates was extracted and included. The AST guidelines that were
used in these studies, were obtained as a data. Due to the passage,
most articles have cited CLSI (27 research) as reference and also
some other AST such as EUCAST and etc. Despite extraction from
AST guidelines data; unfortunately, the data analyzed in unity,
regardless of the differences in the AST guidelines were cited in
the papers. Thus, the disparity in the breakpoint was inherent in
each AST guidelines, for example, in the case of Metronidazole.
The result of AST was presented by EUCAST breakpoint (>2mg/l)
as it is different from the result of a report based on CLSI breakpoint
(32mg/l). They also analyzed articles with another AST breakpoint
in a single batch. Therefore, the total resistance values and propor-
tion does not accurately correlate. The results of continental sub-
group analysis get an error due to the generality of using
particular AST guideline in each continent.
Our recommendation for conducting a systematic review and
Meta-analysis in this subject, especially at the global level, primar-
ily, is to develop a suitable questionnaire of quality assessment for
the study and perform it accurately. Analyzing the results of the
quality assessment as a subgroup to discover the relation between
quality of studies on reported resistance rate, in order to identify
the risk bias of poor-quality studies. Accordingly, the presence of
various AST guidelines causes multiple breakpoints in use. It is
advisable to categorize the data according to the reported break-
point for each piece in order to obtain an accurate antibiotic resis-
tance rate. It should be mentioned that the results of the analysis
based on each AST guidelines breakpoint should be categorized
separately.References
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